- MyIllumina
- Tools
TruSeq Custom Enrichment is an in-solution capture assay for targeting and enriching user-selected human genomic regions of ~700 kb - 15 Mb of cumulative DNA per sample for fully-customized resequencing. The assay is ideal for targeting specific genomic content, such as variant validation, examination of specific genes in pathways, or as a follow-up to GWAS.
Custom oligonucleotide probes are first designed and ordered in DesignStudio. The TruSeq Custom Oligo Set consists of 2,500 to 67,200 attempted custom oligos. TruSeq Custom Enrichment is fully integrated with TruSeq DNA Sample Preparation Kits for an optimized, gel-free workflow.
Based on the total number of samples requested, the TruSeq Custom Oligo Set also includes sufficient 24- or 96-reaction TruSeq Custom Enrichment reagent kits. Through pre-enrichment sample pooling of up to 12 samples, each 24-reaction kit can support up to 288 samples, and each 96-reaction kit supports up to 1,152 samples.
Start a new TruSeq Custom Enrichment project »
Learn more about DesignStudio »
Learn more about TruSeq technology.
Catalog IDs: FC-121-0200, FC-123-1024, FC-123-1096
Product Literature
| TruSeq Custom Enrichment Kit Data Sheet |
| TruSeq Sample Prep Kits Data Sheet |
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.